Name: The Price is Right? – Delivering UK access for niche patient populations
Start: 2014-12-08T16:00:00Z
End: 2014-12-08T17:30:55.000Z
Location: BrightTALK
Rating: 4.17

pharmaphorum provides a digital podium for communicating thought leadership and innovation within pharma. Our webinars bring together different stakeholders from across the healthcare spectrum to drive fresh thinking and novel solutions that deliver better outcomes for patients.

Join us to learn about the pivotal role oncology PSPs can continue to play in cancer care, and the opportunities and challenges AI-powered digital cancer support platforms present to clinicians and drug makers. How close is the vision and promise to reality, and how can you tap into these next-generation digital oncology platforms to create and deliver value for your patients and your organisation?

How can digital and AI optimise delivery of patient support programs in cancer?

In this webinar, brought to you by Complete HealthVizion, three experts on MSL training will discuss the current challenges and opportunities for MSLs, the skills they need to meet those challenges, and new strategies and technologies that can be used to impart those skills.

Meeting MSL training needs in an evolving landscape

Patient centricity is a high priority these days for pharma companies, who are discovering the value of letting patients’ needs guide the development of therapies and interventions, not only to the patients but to their own outcomes and bottom lines. 

But as with any culture change, it’s important to be able to measure the change and measure its affects – or is it?

In this webinar, brought to you by the company behind A Life in a Day, patient centricity experts will draw from their own experiences to debate questions around how and why to measure these initiatives. Is it important to measure impact and prove outcomes, or is it enough to improve the patient experience for its own sake? Is it even possible to create meaningful measurements for patient centric activities, and if so, what do those measurements look like?

Join us on Wednesday, 7th December at 1 pm BST as panelists share insights and lessons from their own professional life to explore these important questions.

This webinar will also explore: 

• What meaningful patient experiences can look like and how they can affect treatment outcomes
• How to leverage the voice of the patient in creating interventions
• What KPIs are important to measure and how best to measure them

Attendees will leave with energised and educated about patient centricity, how to achieve it, and how to benchmark those achievements.

What is the true value of a “patient centric” initiative?

In this webinar, sponsored by IQVIA, the panel will discuss how the Innovative Medicines Fund works, what the implications are for industry organisations in securing funding via this route, and how this will influence uptake of medicines recommended via a NICE technology appraisal.

IMF and the opportunity for ICSs to mobilise NICE approvals

From diagnosis to treatment and ongoing condition management, the patient journey is becoming an increasingly digitized one – a process which has been massively accelerated by the Covid pandemic and has significant implications for pharmaceutical & their patients vs. their customers. 

Join us on Monday 7th November at 12:30 GMT / 13:30 CET / 7:30 am EDT as panellists lay out how a better approach to communication can lead to improved patient ou This panel will focus on how this new paradigm is shaping both the industry’s omnichannel engagement and the patient care journey, from patient identification / engagement, through telehealth, Rx fulfilment / coverage, and into ongoing support programs and adherence.

How the Digital Patient Experience is Shaping the Future of Pharma

In this webinar, sponsored by IQVIA, speakers from The Medical Informatics Group at the University Hospital Frankfurt and the Collaboration on Rare Diseases in Medical Informatics project, Germany will discuss the potential of medical informatics in rare disease research and treatment. They will also provide insight into current problems, future challenges and new ideas across the bridge between rare diseases and medical informatics.

Medical Informatics and Rare Disease: a bridge between two worlds

Join us on Tuesday 26th April for a webinar, bought to you in association with IQVIA, where key industry figures from IQVIA and Boehringer Ingelheim, along with Integrated Care System Strategy experts, will be discussing the future of the Health and Care Bill and the importance of collaborations between ICS leaders to address system readiness to improve population health.

ICSs - an opportunity to improve Patient & Market Access at a local level

In today’s competitive global market, pharmaceutical companies cannot afford to waste time or resources on strategies that do not fit patient needs or generate scripts. Interconnectivity between all stakeholders and a 360° view of everything that touches the patient are essential when mapping each patient’s and HCP’s unique and differentiated journey. But how do you ensure you are making the right connections and ensuring all key stakeholders have access to tailored education around treatments?  

In this webinar, brought to you by EVERSANA™, digital communication and design experts will dive into the history of digital communication in healthcare — and how digital channels are changing how pharma interacts with stakeholders

Is your digital communication strategy up to par?

Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on next steps is harder to find. The growth of a start-up after obtaining Series A funding is a transformational phase when scaling up the company becomes critical. The CEO can experience pressure to deliver on the revenue growth goals, whilst still developing their product, growing the team, and implementing core processes for the company. 

In this webinar, we will discuss the challenges CEOs face and their personal journey during this exciting stage of entrepreneurship. Panel discussions will be based around the recent publication The Digital Health Start-up Journey: From Series A to scaling up.

The Digital Health Start-up Journey: Series A to scale-up

The primary care setting offers huge potential for commercial research. This was, and still is being, demonstrated through the UK’s COVID-19 vaccine research successes.  But tapping into that potential requires companies to understand and to plan for primary care. In this session, we will unpick some of the common challenges faced by companies when initiating research in this setting.

Conducting successful commercial research in a primary care setting

In this webinar, speakers from the NIHR and Roche will discuss what data is available to life science companies and CROs, how it’s currently being used for research planning and placement, and what more could be done with that data. They’ll also look at what culture and process changes will be required to make sure this data can be readily translated into insights to improve commercial research delivery.

Unlocking the potential of healthcare data for commercial clinical research

In a fireside chat hosted by pharmaphorum’s Jonah Comstock, Healthware Group CEO Roberto Ascione (author of the recent book “The Future of Health”) and Politecnico di Milano Professor Emanuele Lettieri will discuss recent trends in digital transformation in healthcare and life sciences that prompted the creation of the Programme as well as share a little about the programme itself. Comstock, Ascione, and Lettieri will discuss each of the modules mentioned above and dive into what innovators can do to prepare their organisations to meet this exciting future.

Preparing industry leaders for digital transformation

Synthetic Control Arms (SCAs) have the potential to reduce the number of trial participants, eliminate delays, and lower costs. In this webinar experts from the worlds of clinical trials and clinical AI will present and discuss the factors to consider when planning to use an SCA as part of a clinical trial.

How can synthetic control arms & real-world data redefine clinical trial design?

As the COVID-19 pandemic continues to impact the healthcare landscape, and the digital transformation of the life sciences industry gathers pace, what can we expect to see in 2022? 

In this webinar, senior members from Healthware Group discuss the key trends and developments set to shape the industry and present their predictions for the year ahead. Join us on Friday 21 January at 2.00pm CET to find out how life science companies can stay ahead of the competition in 2022.

Plus, webinar attendees will have the opportunity to receive a free copy of the newly published book, “The Future of Health, How Digital Technology Will Make Care Accessible, Sustainable, and Human”, which expands on these topics (while supplies last).

Life Sciences Predictions for 2022

Once widely acknowledged as so special that only scientists and clinical specialists need apply, oncology has become exponentially more clinically targeted and sophisticated over the last decade.
 
Yet how many other therapy areas have market leaders that don’t even have clinical approval in that indication?

Immunotherapies are the scientific answer to cancer, how important is marketing?

This webinar will take place on Tuesday 9th November at 12:00 pm GMT / 1:00 pm CET.

Far more common than initially thought, rare disease treatments remain far too scarce. The answer to the problem, of course, lies in making both academic and commercial medical research more efficient and effective.

This webinar will share more information about how to work more collegially with academics, industry and patient groups to ultimately improve the care and treatment of patients with rare diseases.

Drug development and how best to work with specialised Rare Disease networks

The exact shape of healthcare’s post-COVID ‘new normal’ is still being framed, but it is clear that some trends are already taking shape - and one of the key ones is digital transformation in pharma.

This pharmaphorum webinar, held in association with P360, takes place on Wednesday 19th May 08:00 PST / 16:00 BST / 17:00 CET and will look at the long-term implications of healthcare’s pandemic-powered digital transformation.

The digital transformation of pharma’s physician engagement strategies

With recent market changes catalysing a rapid shift to an omnichannel approach, life science organisations of every size are racing to adapt their commercial approach to be more relevant, coordinated and personalised to the needs of each HCP. 

Focus
This pharmaphorum webinar, held in association with Aktana, will take place on 29th April 2021 at 15:00 BST / 10:00 EDT.

Using AI to make a big impact for emerging and mid-sized biopharma companies

With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again  – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes to defined patient populations in the UK and how can pharma navigate seemingly choppy waters of access for rare disease treatments and orphan drugs?

Working in partnership with IMS Health, pharmaphorum has assembled an expert panel including NHS England’s Malcolm Qualie, Alan Kane of Shire Pharmaceuticals, Angela McFarlane of IMS Health, the Cystic Fibrosis Trust's Nick Medhurst and pharmaphorum’s own Paul Tunnah to present and debate around these issues in a free to attend one hour webinar.

This event will cover:
•  Access, in the UK, to higher priced drugs/innovative treatments
•  Rare Disease/Orphan Drug access in the UK   
•  The evolution of the Cancer Drugs Fund - what does this look like, what could it mean for pharma/healthcare 

It will also enable frank discussion around the new NHS England processes.

The Price is Right? – Delivering UK access for niche patient populations

Market

Access

Pharma

Rare

diease

cancer

drug

Get powerful marketing insights for your business. Connect with experts and colleagues to get the most up-to-date knowledge on which marketing strategies and techniques are driving customer and revenue growth.

Marketing

The marketing community on BrightTALK is made up of thousands of engaged marketing professionals. Find relevant webinars and videos on marketing strategy, branding and more presented by recognized thought leaders. Join the conversation by participating in live webinars and round table discussions.

The medical research community on BrightTALK brings together medical and research professionals. Find relevant webinars on medical research, laboratory science, continuing medical education and more presented by recognized medical researchers. Join the conversation by participating in live webinars and round table discussions on the latest in medical devices, medical research practices and trends in the healthcare industry.

Medical Research

Thousands of healthcare IT professionals compose the health IT community on BrightTALK. Learn alongside them with relevant webinars on healthcare IT compliance, big data in healthcare and IT solutions for healthcare organizations. Join the conversation by asking questions and engaging with other participants during live webinars and organized discussions.

Health IT

Get powerful life science insights from influential experts. Connect with thought leaders and colleagues to get the most up-to-date knowledge on strategies and initiatives to accelerate the transformation of U.S. and global health care from a volume- to value-based marketplace.

Life Sciences

The research and development community on BrightTALK brings together leading professionals in healthcare, technology and manufacturing to present on current topics in their fields. From big data in healthcare to online forensics training and medical research practices, the community is an exceptional resource for those looking to expand their knowledge. Be part of the conversation by joining the community and participating in interactive live webinars.

The Price is Right? – Delivering UK access for niche patient populations

Presented by

About this talk

More from this channel